Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CBDMEDIC is a line of over-the-counter topical pain relief products formulated for temporary relief of minor aches and pains of muscles and joints associated with arthritis, backache, strains, sprains or sports-related injuries. The primary active pharmaceutical ingredients are menthol (typically 4%) and camphor in some formulations. These are combined with natural emollients (such as shea butter), essential oils (including clove oil and eucalyptus oil), beeswax and THC-free hemp extract or oil. While the product contains cannabidiol (CBD) derived from industrial hemp as an inactive ingredient for its emollient properties or potential skin benefits, the analgesic effect is attributed to menthol (and camphor where present). The products do not contain artificial dyes or synthetic fragrances[2][3][6]. Developed by Abacus Health Products in 2019 after years of research into natural pain-relief formulations[3][5], all products are manufactured in cGMP-compliant facilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CBDMEDIC.